Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsIn 2021, Inc. Magazine has again named Modality Solutions to the publication’s annual Inc. 5000 list, the most prestigious ranking of America’s successful, fast-growing private companies. This is the third consecutive year that Modality Solutions has been recognized by Inc. magazine.
“Our growth at Modality Solutions has been consistent year over year, and we’ve continued to see that into 2021,” said Gary Hutchinson, co-founder and President. “This is especially meaningful this year as our clients have continued to turn to us as a critical partner despite the ongoing global pandemic. Our ability to help our clients achieve regulatory success, including those working on emergency use authorizations or accelerated approval pathways, has allowed us to have very significant growth even amidst economic uncertainty.”
Also in 2021, the Houston-based firm was ranked the fastest growing engineering firm in the Inc Texas Regionals.
To view our full Inc. 5000 press release for 2021, click here.
See also:
Modality Solutions Recognized on Inc. Magazine’s List of Fastest-Growing Private Companies in Texas
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsCongratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details